La tirzepatida (15 mg una vez a la semana), un agonista dual que acta sobre los receptores GLP-1 y GIP, produjo una prdida de peso de hasta el 17,8% despus de 72 semanas , y la semaglutida (2,4 mg una vez a la semana) produjo una prdida de peso de hasta el 13,9% despus de 68 semanas, ambas en comparacin con placebo
For patients who prefer oral medication, Semaglutide (Rybelsus) provides a daily pill option, while Ozempic is available for weekly injections
We are here to guide you through every stepfrom your first injection to your final goalensuring you feel supported and informed throughout the process
Evening: Others choose to sleep through initial side effects, such as mild nausea, if possible
Dual receptor agonist action: Tirzepatid is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist [1,2](Wong E, 2023